Vioxx (Rofecoxib) is a drug used to relieve osteoarthritis, rheumatoid arthritis as well as acute pain and menstrual symptoms.

Since its introduction in 1999 people around the world have been prescribed Vioxx for these types of medical problems. In the US there have been over 90 million users of the drug.

There is concern that the regular use of Vioxx causes some serious side effects including problems related to kidney and cardiovascular health, and the increased risk of heart attack and stroke.

On September 30, 2004 the manufacturer of the drug Merck has voluntarily recalled Vioxx. However litigation and class actions are being brought about regarding complications detailed in a FDA approved study relating to the severe side effects including increased chances of heart attack and stroke.

Symptoms of heart attack include chest pain, shortness of breath, impaired thinking, rapid heart beat, loss of appetite, edema and fatigue. Symptoms of stroke include numbness to one side of the body, vision impairment, dizziness, and trouble speaking or problems with motor skills.


News 8/18/2006

A New Orleans jury on Thursday ruled against Merck & Co. in the latest trial concerning embattled pain killer Vioxx, ordering the company to pay $51 million to a man who blamed his heart attack on the drug.

The jury ruled that the Whitehouse Station, N.J., pharmaceutical maker, which is building a $300 million plant in Durham, failed to provide ample warning to physicians about risks associated with the drug, according to reports from a number of media outlets covering the trial in Louisiana.

The company must now pay $50 million to compensate 62-year-old Gerald Barnett, 62, a former FBI agent, for a heart attack that he says was caused by Vioxx. The jury also awarded $1 million in punitive damages.

More than 16,000 lawsuits have been filed against Merck regarding Vioxx.

Merck has now lost four cases concerning Vioxx – one each in Louisiana and New Jersey and two in Texas. It has won one federal case and four state cases in New Jersey and California.

Vioxx was pulled from the market last year after studies found long-term use of the drug increased a patient’s risk for heart attack or stroke.

Merck (NYSE: MRK) has been promisted $40 million in state incentives to build a 250,000-square-foot vaccine plant in Durham that would create 200 jobs. The company has said the facility is on track for completion in 2007 or 2008.


Bad Behavior has blocked 627 access attempts in the last 7 days.